Scroll to top

Scroll to top

News Releases

Home
Investors
News Releases

News Releases

Month Year

Month Year

Investor Alerts

June 2, 2025

Immunic to Participate in Investor, Scientific and Industry Conferences in June
May 29, 2025

Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering
May 28, 2025

Immunic, Inc. Announces Proposed Public Offering
May 2, 2025

Immunic to Participate in Scientific and Industry Conferences in May
April 30, 2025

Immunic Announces Vidofludimus Calcium Reduced Risk of Disability Worsening by 30% in Primary Progressive Multiple Sclerosis Patients from Phase 2 CALLIPER Trial

Show per page